This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Buy Stocks for April 5th
by Zacks Equity Research
KBH, GS, TBI, ABCB, and FIX have been added to the Zacks Rank #1 (Strong Buy) List on April 5, 2021.
The Zacks Analyst Blog Highlights: Korn Ferry, Kforce, Cross Country Healthcare, Heidrick & Struggles International and TrueBlue
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Korn Ferry, Kforce, Cross Country Healthcare, Heidrick & Struggles International and TrueBlue
Record-Low Jobless Claims Show Labor Market Recovery: 5 Picks
by Nalak Das
We have narrowed down our search to five staffing stocks that have provided double-digit return year to date and still have more upside. These are: KFY, KFRC, TBI, CCRN and HSII.
Is TrueBlue (TBI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Staffing Stocks Set to Gain From Potential Fall in Jobless Rate
by Kaustav Ghosh
The Fed has forecast a fall in unemployment rate which bodes well for the U.S. labor market, making it wise to invest in names like Kforce (KFRC) and TrueBlue (TBI)
5 Top Staffing Stocks to Win Big on Blowout Jobs Report
by Tirthankar Chakraborty
With U.S. jobs growth breezing past expectations in February and hiring poised to pick up, investing in staffing stocks like Kforce (KFRC), TrueBlue (TBI) & KornFerry International (KFY) seems prudent.
Is TrueBlue (TBI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in Store for Republic Services (RSG) in Q4 Earnings?
by Zacks Equity Research
Republic Services' (RSG) fourth-quarter 2020 earnings and revenues are likely to have decreased year over year.
Verisk (VRSK) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Verisk's (VRSK) fourth-quarter 2020 revenues are likely to reflect strength across Insurance, and Energy, and Specialized Markets segments.
TrueBlue (TBI) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 65.00% and 4.86%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
TrueBlue (TBI) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 1100.00% and 3.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TrueBlue (TBI) Q3 Earnings Expected to Decline
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is TrueBlue (TBI) Stock a Suitable Pick for Value Investors?
by Zacks Equity Research
Let's see if TrueBlue, Inc. (TBI) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
TrueBlue (TBI) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 69.23% and 4.31%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TrueBlue (TBI) Q2 Earnings Expected to Decline
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TrueBlue (TBI) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of -111.11% and -3.09%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TrueBlue (TBI) Q1 Earnings Expected to Decline
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress
by Sweta Jaiswal, FRM
The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Moving Average Crossover Alert: TrueBlue
by Zacks Equity Research
TrueBlue, Inc. (TBI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
TrueBlue (TBI) Q4 Earnings Surpass Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 2.63% and -1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TrueBlue (TBI) Q4 Earnings Expected to Decline
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is TrueBlue (TBI) a Profitable Pick for Value Investors?
by Zacks Equity Research
TrueBlue (TBI) stock may be a good choice for value-oriented investors right now from multiple angles.
7 Low Price-to-Sales Stocks for a Winning Portfolio in 2020
by Zacks Equity Research
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by the company.
Are Investors Undervaluing TrueBlue (TBI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.